As Director, DIA Japan, Ko Sekiguchi is responsible for DIA business and program development in that country. Ko will work closely with the Advisory Council of Japan and its committees, as well as with industry, association, and regulatory counterparts throughout Asia, to enhance and coordinate DIA’s collaborative networking, information exchange, and other efforts in Japan. He will also supervise DIA Japan office staff, and serve on the association’s Global Management Team.
Prior to joining DIA, Ko served for more than a decade as President of Janssen Pharmaceutical K.K., a family company of Johnson & Johnson, and later served as Executive Advisor. He previously served in the medical device industry for Johnson & Johnson Medical K.K. From 2007 to 2009, Ko served as Chairman of the Japan-Based Executive Committee (JBEC) of the Pharmaceutical Research & Manufacturers of America (PhRMA), Japan, and played a key leadership role in discussions that led to the successful implementation of a new drug pricing rule which rewards innovation in the 2010 National Health Insurance drug pricing reform. Ko has also worked for the Mitsubishi Corporation, and for the Tokyo office of the Boston Consulting Group.
Ko has his undergraduate degree from the University of Tokyo and his MBA and MCP from the Massachusetts Institute of Technology (MIT).